These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 18511877
1. Immunohistochemical study of glypican 3 in thyroid cancer. Yamanaka K, Ito Y, Okuyama N, Noda K, Matsumoto H, Yoshida H, Miyauchi A, Capurro M, Filmus J, Miyoshi E. Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877 [Abstract] [Full Text] [Related]
2. Apolipoprotein e expression in anaplastic thyroid carcinoma. Ito Y, Takano T, Miyauchi A. Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558 [Abstract] [Full Text] [Related]
3. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF. Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):458-62. PubMed ID: 16772080 [Abstract] [Full Text] [Related]
4. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, Ito K, Yoshida A, Shimizu K. BMC Cancer; 2006 Nov 01; 6():260. PubMed ID: 17076909 [Abstract] [Full Text] [Related]
5. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS. Int J Oncol; 2009 Jul 01; 35(1):49-55. PubMed ID: 19513551 [Abstract] [Full Text] [Related]
6. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Katoh R, Kawaoi A, Miyagi E, Li X, Suzuki K, Nakamura Y, Kakudo K. Mod Pathol; 2000 May 01; 13(5):570-6. PubMed ID: 10824930 [Abstract] [Full Text] [Related]
7. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. Surgery; 2005 Dec 01; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397 [Abstract] [Full Text] [Related]
13. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Anticancer Res; 2003 Dec 01; 23(5A):3819-24. PubMed ID: 14666683 [Abstract] [Full Text] [Related]
14. Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. Ito Y, Akinaga A, Yamanaka K, Nakagawa T, Kondo A, Dickson RB, Lin CY, Miyauchi A, Taniguchi N, Miyoshi E. Glycobiology; 2006 May 01; 16(5):368-74. PubMed ID: 16464868 [Abstract] [Full Text] [Related]
17. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Cheng SP, Chi CW, Tzen CY, Yang TL, Lee JJ, Liu TP, Liu CL. Surgery; 2010 Jun 01; 147(6):847-53. PubMed ID: 20045163 [Abstract] [Full Text] [Related]
18. Identification of glypican-3 as a novel tumor marker for melanoma. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, Senju S, Ono T, Nishimura Y. Clin Cancer Res; 2004 Oct 01; 10(19):6612-21. PubMed ID: 15475451 [Abstract] [Full Text] [Related]
19. [Morphologic and molecular-genetic characteristics of carcinoma, adenoma and surrounding tissue of the thyroid gland]. Pal'tsev MA, Kogan EA, Tuntsova OI, Severin ES, Silaeva SA, Golenchenko VA. Arkh Patol; 1998 Oct 01; 60(3):5-10. PubMed ID: 9702292 [Abstract] [Full Text] [Related]